U.S. researchers find clues that could one day help predict which women should pass on breast cancer drug Herceptin.
|
U.S. Presidential candidate proposes legislation that would help bring generic versions of biotech drugs to market.
|
Biotech combination will expand sales of Xolair asthma drug.
|
Like his father, Roger Kornberg won the Nobel Laureate for his work in DNA.
|
Government Accountability Office report says at-home genetic tests give troubling results.
|
Roche puts brakes on Avastin trial; Barr buys PLIVA for $2.2B; Cyberonics gets a subpoena.
|
Scientists are finding ways to hack the genetic code.
|
The technology is generating renewed interest in the VC and medical communities.
|
The drug maker’s profits top forecasts, but the stock is dinged on disappointing sales of lymphoma drug.
|
Lymphoma drug from Genentech, Biogen, and Roche OK'd for rheumatoid arthritis.
|
A New Zealand-based biotech company cuts DNA analysis times to 20 minutes.
|
Swiss drug maker files for authorization to market early-stage breast cancer treatment with European Medicines Agency.
|
Pharmaceutical company giants Roche and Genentech suspend recruitment for trials of their colon cancer drug Avastin after patients die.
|
The management consultant breaks down how life science startups become the Genentechs of the world.
|
The chip company is teaming up with the medical device maker Veredus Labs to create tools for detecting the deadly virus.
|
A U.S. move to collect DNA from arrestees helps testing companies, but has civil liberties groups in uproar.
|
Biotech firm wants to sell its anti-blindness treatment, Lucentis.
|
Exact Sciences's improved colorectal cancer test should hit the market in six months.
|
Researchers employ technology used in emailing to solve a well-known problem in detecting gene activation.
|
Strong quarterly Herceptin and Avastin sales cause biotech giant shares to soar.
|
Page
1
of
2
|